Optimizing PARPi in Ovarian Cancer: Practical Guidance on Current Clinical Management Strategies

Review the latest data and expert guidance on PARP inhibitors to enhance your treatment of ovarian cancer. This comprehensive program features decision support tools focused commentaries an expert analysis module and a downloadable slideset.

Share

Program Content

No activities added yet

No activities added yet

Supporters

Supported by independent educational grants from

Clovis Oncology

Tesaro